Green Cross Health Limited (NZX: GXH) Trading update

Tuesday 25th January 2022

Green Cross Health (NZX: GXH ) is currently experiencing higher than anticipated revenue and profitability relative to the prior period. For the 9 months to 31 December 2021, the company has experienced an increase in revenue of approximately 14%.

Group CEO Rachael Newfield said “This uplift is primarily the result of increased COVID-19 related activity across the company’s three divisions of Medical, Pharmacy and Community Health as well as the impact of recent acquisitions in the Medical division. The company notes that this uplift may not continue in full into the next financial year due to the uncertain and changeable outlook for COVID-19 vaccination and swabbing activity”.

Whilst Omicron has introduced further uncertainty, Net Profit After Tax Attributable to Shareholders for the 12 months to 31 March 2022 is projected to exceed the prior period result by $4.5m - $6.5m. Green Cross Health is scheduled to release its audited full year result for the year to 31 March 2022 on 27 May 2022.

Please see the link below for details

GXH Trading Update

Source: Green Cross Health Limited

Comments from our readers

No comments yet